Jingyang Li
- Parasitology top 10%
-
- Rheumatoid Arthritis Research and Therapies 8
- Spondyloarthritis Studies and Treatments 6
- Systemic Lupus Erythematosus Research 3
-
- Liver Disease Diagnosis and Treatment 3
-
- Autoimmune and Inflammatory Disorders Research 5
-
- Psoriasis: Treatment and Pathogenesis 4
-
- Asthma and respiratory diseases 4
-
- Drug Transport and Resistance Mechanisms 3
- Journals
- Chemical Engineering Journal (1 paper)International Journal of Molecular Sciences (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jingyang Li
48 papers receiving 340 citations
Peers
Comparison fields: 5 of 93
- Parasitology 38
- Rheumatology 55
- Molecular Medicine 14
- Epidemiology 64
- Pharmacology 30
Countries citing papers authored by Jingyang Li
This map shows the geographic impact of Jingyang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyang Li more than expected).
Fields of papers citing papers by Jingyang Li
This network shows the impact of papers produced by Jingyang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyang Li. The network helps show where Jingyang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingyang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 15 | |
| 12 | 2023 | 3 | |
| 13 | 2021 | 20 | |
| 14 | 2021 | 3 | |
| 15 | 2020 | 4 | |
| 16 | 2019 | 3 | |
| 17 | 2019 | 38 | |
| 18 | 2018 | 40 | |
| 19 | 2016 | 1 | |
| 20 | Clinical analysis and treat of neuroleptic malignant syndrome | 2010 | 1 |
About Jingyang Li
Jingyang Li is a scholar working on Rheumatology, Immunology and Family Practice, having authored 54 papers that have together received 345 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (8 papers), Spondyloarthritis Studies and Treatments (6 papers), Autoimmune and Inflammatory Disorders Research (5 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Asthma and respiratory diseases (4 papers), Systemic Lupus Erythematosus Research (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Parasitology (38 citations), Rheumatology (55 citations) and Molecular Medicine (14 citations). Jingyang Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Songli Mei, Tingting Gao, Hui Ren, Faustina Pappoe, Wanbo Zhu, Ji-Long Shen, Li Yu, Wei Jia, Shangqin Chen and Jing Lin. Their work appears in journals such as Chemical Engineering Journal, International Journal of Molecular Sciences and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.